SPY332.80-2.77 -0.83%
DIA277.19-0.95 -0.34%
IXIC10,782.82-185.53 -1.69%

UBS Maintains Neutral on Surgery Partners, Lowers Price Target to $17.5

UBS maintains Surgery Partners (NASDAQ:SGRY) with a Neutral and lowers the price target from $19 to $17.5.

Benzinga · -
UBS maintains Surgery Partners (NASDAQ: SGRY) with a Neutral and lowers the price target from $19 to $17.5.